BIO-Europe Spring® 2016: New VC bioqube on open innovation roots and investments targets

April 28, 2016
Nico Vandervelpen, managing partner and co-founder of bioqube ventures—a Johnson & Johnson-partnered venture capital company—chats with Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the young VC’s big plans for the future. Vandervelpen explains the benefits of bioqube's relationship with J&J's JLINX incubator, the VC's open innovation mentality and what it wants to see from startups seeking investment.
Previous Video
BIO-Europe Spring® 2016: Affibody CEO describes three-year growth plan
BIO-Europe Spring® 2016: Affibody CEO describes three-year growth plan

Sten Stovall chats with David Bejker, CEO of Solna, Sweden-based biotech Affibody AB, about development pro...

Next Video
BIO-Europe Spring® 2016: QureTech Bio explains novel approach to antibiotic development
BIO-Europe Spring® 2016: QureTech Bio explains novel approach to antibiotic development

Dr. Fritiof Pontén, CEO of QureTech Bio—one of Sweden's youngest biotech companies—talks with Mike Ward, gl...